Steven Cohen (Point72) trim Keros Therapeutics, Inc.
Steven Cohen (Point72) trim $16.9M of disclosed value in Keros Therapeutics, Inc..
Signal
Investor Move
Action
Trim
Capital
$16.9M disclosed value
Why it matters
This action comes from parsed SEC 13F holdings and highlights where tracked institutional capital changed materially versus the previous comparable filing period.